A breakout stock of the coronavirus era, Teladoc Health (NYSE: TDOC) delivered a third quarter that trounced analyst estimates.
The period saw the telemedicine services specialist book just under $289 million in revenue, which was more than double the Q3 2019 figure, it reported on Wednesday. The company's net loss, however, deepened to $35.9 million, from the year-ago $20.3 million. On an adjusted basis, the latest shortfall was $0.13 per share.
Regardless, both numbers convincingly beat analyst expectations. On average, they predicted almost $282 million on the top line, and a much deeper adjusted per-share net loss of $0.32.
Source Fool.com